Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With DLBCL: a Phase II Multicenter Study of the FIL
Clinical trial NCT01990144 · UNKNOWN
Trial details
- NCT number
- NCT01990144
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2014-02-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.